NEJM Publishes Phase 1/2 Results for Denali Therapeutics’ Brain‑Penetrant Hunter Syndrome Therapy
- January 29, 2026
Comprehensive Cancer Fighter: FDA Fast-Tracks Innovative Breast Cancer Therapy
GLP-1 Therapies Emerge as Key Tools in CKD Prevention—But Long-Term Success Hinges on Patient Engagement
How Shenqi Dihuang Decoction May Target Key Pathways in IgA Nephropathy: New Mechanistic Insights
LISTEN TO OUR PODCAST
THE LATEST FROM PATIENT WORTHY
FEATURED
UPCOMING EVENTS
SIGN UP FOR OUR NEWSLETTER
🌿 IgA Nephropathy (IgAN) often progresses silently for years.
Early symptom recognition and routine kidney checkups can make a meaningful difference in long‑term kidney health.
Your kidneys matter! Stay informed, stay proactive. 💚
#igan #IgANAwareness #igancommunity #kidneyhealth #kidneydiseaseawareness #chronicillnessawareness #autoimmunedisease #HealthEducation #PatientAdvocacy #PatientWorthy #SilentSymptoms
The results are in from Denali's recent phase 1/2 trial for an enzyme-replacement therapy designed to target both cognitive and physical manifestations of Hunter Syndrome. Read more here:
patientworthy.com/2026/01/29/nejm-publishes-phase-1-2-results-for-denali-therapeutics-brain%e2%80...
Jessica Glaspie was born and raised in Zion, IL and currently resides in the DFW area in Texas. She has been living with HIV for 15 years and advocating for over 10 years. At just 22 years old she visited the doctor, complaining of swollen lymph nodes in her neck. Her physician drew some blood and did a biopsy. When the results came back, the doctor delivered harrowing and unexpected news: She had tested positive for HIV. Jessica is the author of the memoir "Life, Love, and HIV" and takes great pride in her advocacy work as an educator and motivational speaker. She is a single mother of 3 beautiful, HIV negative children and loves traveling!
If you are interested in sharing your healthcare journey, click the link: bit.ly/4dV7gru
#HIV #shareyourstory #patientworthy #lifelovehiv
